|

ALN-4324 Clinical Trials

1 actively recruiting trial across 1 location

▼ -1 trial since July 2026

Pipeline

Phase 2: 1

Top Sponsors

  • Alnylam Pharmaceuticals1

Indications

  • Type 2 Diabetes Mellitus (T2DM)1
  • Diabetes1

Chula Vista, California1 trial

A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus

Clinical Trial Site

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.